Biorasis commercializes wireless, needle implantable, miniaturized sensor platforms for real-time glucose monitoring.
Business Model:
Revenue: $20.8M
Employees: 51-200
Address: Unit 4213
City:
State: CT
Zip: 06269
Country: US
BIORASIS was established in Dec. 2007 with an initial goal to commercialize UCONN’s and OSCI’s wireless, needle-implantable, miniaturized (0.5 x 0.5 x 5 mm) sensor platform for real time, continuous glucose monitoring. In addition to glucose monitoring Biorasis is working towards outfitting its sensor platform to monitor other bio-analytes in the body that are important in other disorders such as cardiovascular, cancer, liver, kidney abnormalities, stroke and epilepsy.
Contact Phone:
+18604869188
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2018 | Grant | $0 |
The Leona M. and Harry B. Helmsley Charitable Trust The Leona M. and Harry B. Helmsley Charitable Trust |
10/2015 | Grant | 1 | $100k |
MassChallenge MassChallenge |
8/2012 | Grant | 1 | $696.4k |
National Science Foundation National Science Foundation |
12/2018 | Grant | 1 | $3M |
The Leona M. and Harry B. Helmsley Charitable Trust The Leona M. and Harry B. Helmsley Charitable Trust |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|